512 related articles for article (PubMed ID: 30096387)
1. A novel anti-osteoporotic agent that protects against postmenopausal bone loss by regulating bone formation and bone resorption.
Yang YT; Meng JH; Hu B; Ma CY; Zhao CC; Teng WS; Hong JQ; Li SH; Jiang GY; Wang C; Zhou CH; Yan SG
Life Sci; 2018 Sep; 209():409-419. PubMed ID: 30096387
[TBL] [Abstract][Full Text] [Related]
2. Pitavastatin prevents ovariectomy-induced osteoporosis by regulating osteoclastic resorption and osteoblastic formation.
Cheon YH; Lee CH; Kim S; Park GD; Kwak SC; Cho HJ; Kim JY; Lee MS
Biomed Pharmacother; 2021 Jul; 139():111697. PubMed ID: 34243614
[TBL] [Abstract][Full Text] [Related]
3. Dioscin reduces ovariectomy-induced bone loss by enhancing osteoblastogenesis and inhibiting osteoclastogenesis.
Tao X; Qi Y; Xu L; Yin L; Han X; Xu Y; Wang C; Sun H; Peng J
Pharmacol Res; 2016 Jun; 108():90-101. PubMed ID: 27155058
[TBL] [Abstract][Full Text] [Related]
4. Tea polysaccharide inhibits RANKL-induced osteoclastogenesis in RAW264.7 cells and ameliorates ovariectomy-induced osteoporosis in rats.
Xu H; Yin D; Liu T; Chen F; Chen Y; Wang X; Sheng J
Biomed Pharmacother; 2018 Jun; 102():539-548. PubMed ID: 29587240
[TBL] [Abstract][Full Text] [Related]
5. Anti-perimenopausal osteoporosis effects of Erzhi formula via regulation of bone resorption through osteoclast differentiation: A network pharmacology-integrated experimental study.
Qin XY; Niu ZC; Han XL; Yang Y; Wei Q; Gao XX; An R; Han LF; Yang WZ; Chai LJ; Liu EW; Gao XM; Mao HP
J Ethnopharmacol; 2021 Apr; 270():113815. PubMed ID: 33444724
[TBL] [Abstract][Full Text] [Related]
6. The beneficial effect of icaritin on osteoporotic bone is dependent on the treatment initiation timing in adult ovariectomized rats.
Peng S; Zhang G; Zhang BT; Guo B; He Y; Bakker AJ; Pan X; Zhen W; Hung L; Qin L; Leung WN
Bone; 2013 Jul; 55(1):230-40. PubMed ID: 23486180
[TBL] [Abstract][Full Text] [Related]
7. Anti-Osteoporotic Activity of Harpagoside by Upregulation of the BMP2 and Wnt Signaling Pathways in Osteoblasts and Suppression of Differentiation in Osteoclasts.
Chung HJ; Kim WK; Oh J; Kim MR; Shin JS; Lee J; Ha IH; Lee SK
J Nat Prod; 2017 Feb; 80(2):434-442. PubMed ID: 28106392
[TBL] [Abstract][Full Text] [Related]
8. The bone regenerative effects of fucosterol in in vitro and in vivo models of postmenopausal osteoporosis.
Lee DG; Park SY; Chung WS; Park JH; Shin HS; Hwang E; Kim IH; Yi TH
Mol Nutr Food Res; 2014 Jun; 58(6):1249-57. PubMed ID: 24604889
[TBL] [Abstract][Full Text] [Related]
9. DANCR Mediates the Rescuing Effects of Sesamin on Postmenopausal Osteoporosis Treatment via Orchestrating Osteogenesis and Osteoclastogenesis.
Yang Z; Feng L; Wang H; Li Y; Lo JHT; Zhang X; Lu X; Wang Y; Lin S; Tortorella MD; Li G
Nutrients; 2021 Dec; 13(12):. PubMed ID: 34960006
[TBL] [Abstract][Full Text] [Related]
10. Protective Effect of Ciclopirox against Ovariectomy-Induced Bone Loss in Mice by Suppressing Osteoclast Formation and Function.
Ihn HJ; Lim J; Kim K; Nam SH; Lim S; Lee SJ; Bae JS; Kim TH; Kim JE; Baek MC; Bae YC; Park EK
Int J Mol Sci; 2021 Aug; 22(15):. PubMed ID: 34361069
[TBL] [Abstract][Full Text] [Related]
11. Effects of JSOG-6 on protection against bone loss in ovariectomized mice through regulation of osteoblast differentiation and osteoclast formation.
Chung HJ; Cho L; Shin JS; Lee J; Ha IH; Park HJ; Lee SK
BMC Complement Altern Med; 2014 Jun; 14():184. PubMed ID: 24903150
[TBL] [Abstract][Full Text] [Related]
12. Hederagenin protects mice against ovariectomy-induced bone loss by inhibiting RANKL-induced osteoclastogenesis and bone resorption.
Tian K; Su Y; Ding J; Wang D; Zhan Y; Li Y; Liang J; Lin X; Song F; Wang Z; Xu J; Liu Q; Zhao J
Life Sci; 2020 Mar; 244():117336. PubMed ID: 31972206
[TBL] [Abstract][Full Text] [Related]
13. Hydrogen gas protects against ovariectomy-induced osteoporosis by inhibiting NF-κB activation.
Wu G; Pan L; Sun J; Chen G; Wang S
Menopause; 2019 Jul; 26(7):785-792. PubMed ID: 31083022
[TBL] [Abstract][Full Text] [Related]
14. Jiangu formula: A novel osteoclast-osteoblast coupling agent for effective osteoporosis treatment.
Xu H; Lu X; Li M; Huang X; Yao N; Gan H; Huang X; Zhao Z; Hu Z; Zhao X; Lai Y; Li M; Chen S; Chen Y; Huang D
Phytomedicine; 2024 Jun; 128():155501. PubMed ID: 38471318
[TBL] [Abstract][Full Text] [Related]
15. Flufenamic acid inhibits osteoclast formation and bone resorption and act against estrogen-dependent bone loss in mice.
Zhang S; Huo S; Li H; Tang H; Nie B; Qu X; Yue B
Int Immunopharmacol; 2020 Jan; 78():106014. PubMed ID: 31776093
[TBL] [Abstract][Full Text] [Related]
16. Anti-c-fms Antibody Prevents Osteoclast Formation and Bone Resorption in Co-Culture of Osteoblasts and Osteoclast Precursors In Vitro and in Ovariectomized Mice.
Nara Y; Kitaura H; Ogawa S; Shen WR; Qi J; Ohori F; Noguchi T; Marahleh A; Pramusita A; Kinjo R; Mizoguchi I
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32854340
[TBL] [Abstract][Full Text] [Related]
17. A Novel Rhein Derivative Modulates Bone Formation and Resorption and Ameliorates Estrogen-Dependent Bone Loss.
Jiang M; Wang T; Yan X; Liu Z; Yan Y; Yang K; Qi J; Zhou H; Qian N; Zhou Q; Chen B; Xu X; Xi X; Yang C; Deng L
J Bone Miner Res; 2019 Feb; 34(2):361-374. PubMed ID: 30320929
[TBL] [Abstract][Full Text] [Related]
18. Caffeic acid 3,4-dihydroxy-phenethyl ester suppresses receptor activator of NF-κB ligand–induced osteoclastogenesis and prevents ovariectomy-induced bone loss through inhibition of mitogen-activated protein kinase/activator protein 1 and Ca2+–nuclear factor of activated T-cells cytoplasmic 1 signaling pathways.
Wu X; Li Z; Yang Z; Zheng C; Jing J; Chen Y; Ye X; Lian X; Qiu W; Yang F; Tang J; Xiao J; Liu M; Luo J
J Bone Miner Res; 2012 Jun; 27(6):1298-1308. PubMed ID: 22337253
[TBL] [Abstract][Full Text] [Related]
19. Changes in micro-CT 3D bone parameters reflect effects of a potent cathepsin K inhibitor (SB-553484) on bone resorption and cortical bone formation in ovariectomized mice.
Xiang A; Kanematsu M; Kumar S; Yamashita D; Kaise T; Kikkawa H; Asano S; Kinoshita M
Bone; 2007 May; 40(5):1231-7. PubMed ID: 17347064
[TBL] [Abstract][Full Text] [Related]
20. Andrographolide Inhibits Ovariectomy-Induced Bone Loss via the Suppression of RANKL Signaling Pathways.
Wang T; Liu Q; Zhou L; Yuan JB; Lin X; Zeng R; Liang X; Zhao J; Xu J
Int J Mol Sci; 2015 Nov; 16(11):27470-81. PubMed ID: 26593901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
